What Happened to Celadon Pharmaceuticals (LSE:CEL) After Shareholders Backed Its AIM Exit?

What Happened to Celadon Pharmaceuticals (LSE:CEL) After Shareholders Backed Its AIM Exit? →

Highlights Celadon Pharmaceuticals shareholders approved the cancellation of the company's AIM listing The business had built its profile around a domestic UK cultivation licence for medical cannabis Its exit from London's public markets re…